KZR logo

Kezar Life Sciences, Inc. (KZR)

Profile

Full Name

Kezar Life Sciences, Inc.

Ticker

NASDAQ: KZR

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

June 21, 2018

Indexes

Not included

Website

https://www.kezarlifesciences.com

Employees

55

Key Details

Price

$3.98(+0.25%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(-100.00% YoY)

Annual EPS

-$11.49(+17.93% YoY)

PE ratio

-

Next earnings date

Nov 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $3.98
    KZR price is $3.98

    30-Day Relative Volume

    0.61
    KZR 30-day relative volume is 0.61

    Price Performance

    Price Today change

    +0.25%
    KZR price is up +0.25% today

    Price YTD change

    -40.77%
    KZR price is down -40.77% since January 1st

    Price 1-year change

    -34.75%
    KZR price is down -34.75% year-on-year

    Price 3-year change

    -96%
    KZR price is down -96% over the past 3 years

    Price Range

    Price All-time high

    $363.30
    KZR price is currently -98.90% below its historical high of $363.30

    Price 3-year low

    $3.62
    KZR price is currently +9.94% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $29.15M
    KZR market capitalization is $29.15 million

    Market cap 3-year change

    -95.72%
    KZR market capitalization is down -95.72% over the past 3 years

    Market cap All-time high

    $1.04B
    KZR market capitalization is currently -97.20% below its historical high of $1.04 billion

    Market cap sector rank

    27.11%
    KZR market capitalization is higher than 27.11% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.37%
    KZR shares outstanding is up +0.37% year-on-year

    Shares Outstanding 3-Year Change

    +7.11%
    KZR shares outstanding is up +7.11% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.84
    KZR beta is 0.84

    200-day SMA

    $5.47
    KZR price is currently -27.18% below its 200-day simple moving average

    50-day SMA

    $4.35
    KZR price is currently -8.50% below its 50-day simple moving average

    RSI

    39.97
    KZR 14-day relative strength index is 39.97

    Volume

    0.61
    KZR 30-day relative volume is 0.61

    ATR

    $0.17
    KZR average true range is $0.17

    10-day Historical Volatility

    22.83%
    KZR 10-day historical volatility is 22.83%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    KZR annual revenue is $0.00

    Revenue Analysts estimate

    -
    KZR annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -100%
    KZR annual revenue is down -100% year-on-year

    Revenue Sector rank

    28.58%
    KZR annual revenue is higher than 28.58% of companies in Healthcare sector

    EPS

    EPS

    -$11.49
    KZR annual earnings per share is -$11.49

    EPS Analysts estimate

    -$7.53
    KZR annual earnings per share is currently +52.52% higher than the consensus analysts' forecast

    EPS 1-year change

    +17.93%
    KZR annual earnings per share is up +17.93% year-on-year

    EPS Sector rank

    11.2%
    KZR annual earnings per share is higher than 11.2% of companies in Healthcare sector

    Profit

    Gross profit

    -$1.04M
    KZR annual gross profit is -$1.04 million

    Gross margin

    -
    KZR annual gross profit margin value is unknown

    Operating profit

    -$89.14M
    KZR annual operating income is -$89.14 million

    Operating margin

    -
    KZR annual operating profit margin value is unknown

    Net income

    -$83.74M
    KZR annual net profit is -$83.74 million

    Net margin

    -
    KZR annual net profit margin value is unknown

    Expenses

    Total expenses

    $89.14M
    KZR annual total expenses is $89.14 million

    Operating expenses

    $89.14M
    KZR annual total operating expenses is $89.14 million

    Cost of goods sold

    $1.04M
    KZR annual cost of goods sold is $1.04 million

    Selling, general & administrative expenses

    $23.39M
    KZR annual SGA is $23.39 million

    Depreciation and amortization

    $1.04M
    KZR annual depreciation & amortization is $1.04 million

    Interest expense

    $0.00
    KZR annual interest expense is $0.00

    Income tax

    $0.00
    KZR annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$82.14M
    KZR annual earnings before interest & taxes is -$82.14 million

    EBITDA

    -$81.10M
    KZR annual EBITDA is -$81.10 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $144.68M
    KZR annual total assets is $144.68 million

    Non current assets

    $7.19M
    KZR annual long term assets is $7.19 million

    Current assets

    $137.49M
    KZR annual total current assets is $137.49 million

    Cash and cash equivalents

    $41.75M
    KZR annual cash & cash equivalents is $41.75 million

    Accounts receivable

    $0.00
    KZR annual accounts receivable is $0.00

    Inventory

    $0.00
    KZR annual inventory is $0.00

    Liabilities

    Total liabilities

    $27.77M
    KZR annual total liabilities is $27.77 million

    Long term liabilities

    $7.44M
    KZR annual total long term liabilities is $7.44 million

    Current liabilities

    $20.33M
    KZR annual total current liabilities is $20.33 million

    Accounts payable

    $3.65M
    KZR annual accounts payable is $3.65 million

    Debt

    Total debt

    $16.18M
    KZR annual total debt is $16.18 million

    Total debt 1-year change

    -14.54%
    KZR annual total debt is down -14.54% year-on-year

    Long term debt

    $7.44M
    KZR annual long term debt is $7.44 million

    Short term debt

    $8.74M
    KZR annual short term debt is $8.74 million

    Equity & Capital

    Shareholders equity

    $116.92M
    KZR annual stockholders equity is $116.92 million

    Book value

    $116.92M
    KZR annual book value is $116.92 million

    Retained earnings

    -$434.50M
    KZR annual retained earnings is -$434.50 million

    Working capital

    $117.16M
    KZR annual working capital is $117.16 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$74.21M
    KZR annual cash flow from operations is -$74.21 million

    Cash from operations 1-year change

    +9.1%
    KZR annual cash flow from operations is up +9.1% year-on-year

    Cash from investing

    $80.43M
    KZR annual cash flow from investing activities is $80.43 million

    Cash from investing 1-year change

    +5.76%
    KZR annual cash flow from investing activities is up +5.76% year-on-year

    Cash from financing

    $103.00K
    KZR annual cash flow from financing activities is $103.00 thousand

    Cash from financing 1-year change

    -83.86%
    KZR annual cash flow from financing activities is down -83.86% year-on-year

    CAPEX

    CAPEX

    $29.00K
    KZR annual capital expenditures is $29.00 thousand

    CAPEX 1-year change

    -98.4%
    KZR annual capital expenditures is down -98.4% year-on-year

    Free Cash Flow

    Free cash flow

    -$74.24M
    KZR annual free cash flow is -$74.24 million

    Free cash flow 1-year change

    +11.04%
    KZR annual free cash flow is up +11.04% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    KZR annual gross profit margin value is unknown

    Operating margin

    -
    KZR annual operating profit margin value is unknown

    Net margin

    -
    KZR annual net profit margin value is unknown

    ROA & ROE

    ROA

    -45.77%
    KZR annual return on assets is -45.77%

    ROE

    -55.00%
    KZR annual return on equity is -55.00%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    KZR price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    KZR price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.32
    KZR price to book ratio is 0.32

    PB ratio Sector rank

    21.7%
    KZR price to book ratio is higher than 21.7% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    KZR price to sales ratio value is unknown

    PS ratio Sector rank

    -
    KZR price to sales ratio is unknown

    Enterprise value

    Enterprise value

    -$71.70M
    KZR enterprise value is -$71.70 million

    Enterprise value Sector rank

    2.25%
    KZR enterprise value is higher than 2.25% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    0.96
    KZR EV/EBITDA is 0.96

    EV/EBITDA Sector rank

    73.16%
    KZR EV/EBITDA is higher than 73.16% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    6.76
    KZR annual current ratio is 6.76

    Quick ratio

    6.76
    KZR annual quick ratio is 6.76

    Leverage

    Debt to equity

    0.14
    KZR annual debt to equity ratio is 0.14

    Interest coverage ratio

    -
    KZR annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    KZR piotroski f-score value is unknown

    Altman Z-Score

    -4.48
    KZR altman z-score is -4.48

    Analyst ratings

    Recent major analysts updates

    Jul 16, 25 HC Wainwright & Co.
    Neutral
    Dec 19, 24 Wells Fargo
    Equal-Weight
    Dec 2, 24 HC Wainwright & Co.
    Neutral
    Nov 14, 24 Wells Fargo
    Equal-Weight
    Oct 18, 24 HC Wainwright & Co.
    Neutral
    Oct 14, 24 HC Wainwright & Co.
    Neutral
    Oct 2, 24 HC Wainwright & Co.
    Neutral
    Aug 14, 24 HC Wainwright & Co.
    Buy
    Jul 22, 24 HC Wainwright & Co.
    Buy
    May 10, 24 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with KZR included

    Growing Shares Outstanding
    US stocks
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Biotech Companies
    • What is the ticker symbol for Kezar Life Sciences, Inc.?
    • Does Kezar Life Sciences, Inc. pay dividends?
    • What sector is Kezar Life Sciences, Inc. in?
    • What industry is Kezar Life Sciences, Inc. in?
    • What country is Kezar Life Sciences, Inc. based in?
    • When did Kezar Life Sciences, Inc. go public?
    • Is Kezar Life Sciences, Inc. in the S&P 500?
    • Is Kezar Life Sciences, Inc. in the NASDAQ 100?
    • Is Kezar Life Sciences, Inc. in the Dow Jones?
    • When was Kezar Life Sciences, Inc.'s last earnings report?
    • When does Kezar Life Sciences, Inc. report earnings?

    What is the ticker symbol for Kezar Life Sciences, Inc.?

    The ticker symbol for Kezar Life Sciences, Inc. is NASDAQ:KZR

    Does Kezar Life Sciences, Inc. pay dividends?

    No, Kezar Life Sciences, Inc. does not pay dividends

    What sector is Kezar Life Sciences, Inc. in?

    Kezar Life Sciences, Inc. is in the Healthcare sector

    What industry is Kezar Life Sciences, Inc. in?

    Kezar Life Sciences, Inc. is in the Biotechnology industry

    What country is Kezar Life Sciences, Inc. based in?

    Kezar Life Sciences, Inc. is headquartered in United States

    When did Kezar Life Sciences, Inc. go public?

    Kezar Life Sciences, Inc.'s initial public offering (IPO) was on June 21, 2018

    Is Kezar Life Sciences, Inc. in the S&P 500?

    No, Kezar Life Sciences, Inc. is not included in the S&P 500 index

    Is Kezar Life Sciences, Inc. in the NASDAQ 100?

    No, Kezar Life Sciences, Inc. is not included in the NASDAQ 100 index

    Is Kezar Life Sciences, Inc. in the Dow Jones?

    No, Kezar Life Sciences, Inc. is not included in the Dow Jones index

    When was Kezar Life Sciences, Inc.'s last earnings report?

    Kezar Life Sciences, Inc.'s most recent earnings report was on August 13, 2025

    When does Kezar Life Sciences, Inc. report earnings?

    The next expected earnings date for Kezar Life Sciences, Inc. is November 14, 2025
    On this page